TSW
IPXL

Thompson Siegel & Walmsley’s Impax Laboratories, Inc. IPXL Stock Holding History

Thompson Siegel & Walmsley’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14,000
Closed -$177K – 927
2017
Q1 		$177K Buy
+14,000
New +$169K ﹤0.01% 458
2015
Q4 		– Sell
-4,900
Closed -$173K – 740
2015
Q3 		$173K Buy
+4,900
New +$221K ﹤0.01% 385
2014
Q3 		– Sell
-421,581
Closed -$12.6M – 712
2014
Q2 		$12.6M Buy
+421,581
New +$11.4M 0.25% 173
2013
Q3 		– Sell
-23,900
Closed -$477K – 686
2013
Q2 		$477K Buy
+23,900
New +$424K 0.01% 332

Other funds holding IPXL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return